Journal of Vascular Surgery
Volume 52, Issue 5 , Pages 1135-1139, November 2010

The value of the initial post-EVAR computed tomography angiography scan in predicting future secondary procedures using the Powerlink stent graft

Presented at the Thirty-eight Annual Symposium of the Society for Clinical Vascular Surgery, April 7-10, 2010, Scottsdale, Ariz.

  • Mitul S. Patel, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Mitul Suresh Patel, MD, Cooper University Hospital, Department of Surgery, 3 Cooper Plaza, Ste 411, Camden, NJ 08103
  • ,
  • Jeffrey P. Carpenter, MD

Division of Vascular Surgery, Department of Surgery, Cooper University Hospital, Robert Wood Johnson Medical School, Camden, NJ

Received 19 March 2010; accepted 3 June 2010. published online 23 July 2010.

Objective

Current long-term surveillance after endovascular abdominal aortic aneurysm repair (EVAR) is based on high-resolution contrast-enhanced computed tomography (CT) scans at scheduled, lifelong intervals. The cancer and nephrotoxicity risks of interval CT scanning and prolonged radiation exposure are concerning. We sought to determine if surveillance CT angiography (CTA) can be safely reduced.

Methods

From July 2000 to November 2007, 345 patients were enrolled in U.S. Food and Drug Administration trials of the Powerlink System (Endologix, Irvine, Calif). An independent core laboratory analyzed 1519 post-EVAR CT scans (N = 1519) to 5 years to evaluate aneurysm size, migration, presence of endoleak, and evidence of graft obstruction. Analyses were conducted to determine the value of the initial CTA scan in predicting future secondary procedures in enrolled patients.

Results

At any time during follow-up, CTA identified endoleak in 123 patients (36%), with 95% of endoleaks being type II. In addition, 49 patients underwent 72 secondary procedures at a mean of 22 ± 21 months (range, 2-2007 days) after initial EVAR. These were based on clinical identification of limb ischemia in 13 interventions (18%) or core laboratory identification of abnormal CT finding in 58 interventions (81%). Of the 58 core laboratory identified findings, the inciting abnormality was present on the initial postoperative scan in 49 (84%). Of the remaining nine CT-driven procedures, three (5.2%) were due to late sac expansion attributed to type II endoleak (n = 2) or endotension (n = 1); two (3.4%) were for prophylactic reasons in the absence of endoleak; and four (6.8%) were in patients with type II endoleak not observed by the core laboratory and without sac expansion. The negative predictive value of the initial postoperative CTA for the need for a secondary procedure is therefore 96.4%, which can be improved to 97.6% with duplex ultrasound surveillance to detect sac expansion. Thus, a negative initial postoperative CTA is highly predictive of long-term freedom from secondary intervention.

Conclusions

Among enrolled patients with suitable anatomy for EVAR, most abnormalities that result in a secondary procedure are detected on the initial postoperative CTA or present with clinical symptoms. Long-term surveillance CTA may therefore be replaced by duplex ultrasound imaging if the initial postoperative CTA shows no abnormalities.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Competition of interest: Dr Carpenter is a consultant for Endologix, Inc.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(10)01353-4

doi:10.1016/j.jvs.2010.06.019

Journal of Vascular Surgery
Volume 52, Issue 5 , Pages 1135-1139, November 2010